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Empyema remains a challenge for modern medicine. Cases not amenable to lung decortication are particularly diﬃcult to
treat, requiring prolonged hospitalizations and mutilating procedures. This paper presents the current role of thoracomyoplasty
procedures, which allow complete and deﬁnitive obliteration of the infected pleural space by a combination of thoracoplasty and
the use of neighbourhood muscle ﬂaps (latissimus dorsi, serratus anterior, pectoralis, rectus abdominis, omentum, etc). Recent
publications show an overall rate of success of 90%, with a quick and deﬁnitive healing. Although rarely indicated in our days,
this kind of procedures remain in the armamentarium of modern thoracic surgery. The importance of thoracomyoplasty derives
from the fact that it may be a simple and deﬁnitive solution for complicated cases of chronic empyema not amenable to standard
decortication.
1.Introduction
Despite obvious recent advances, empyema remains a chal-
lenge for modern medicine. It is a common disease in
chest medicine involving important costs and resources, the
overall mortality is still high, and the best treatment is still
to be deﬁned [1–3]. Surgery is particularly very reluctant
to the principles of evidenced-based medicine and very
much of the current practice is based on “local protocols”
and “personal experience” [4]. The recent recrudescence of
tuberculosis (TB) has also brought to attention the pleural
complications of this disease [5]. The aim of this paper is
to present the current indications, principles, and results of
thoracomyoplasty procedures for empyema.
2. HistoricalBackground
Empyema is known since Hippocrates, who described the
clinical signs and recommended open drainage using cautery
[6].However,lackofknowledgeaboutthepleuralphysiology
made diﬃcult the early attempts of surgical treatment.
Modern management of the empyema starts with the
work of the Empyema Commission led by Bell and Graham
during World War I. This Commission was created by
the US Army to ﬁnd a solution to the high mortality of
patients with parapneumonic empyema. They found that
most deaths were the result of the open pneumothorax
with lung collapse and respiratory failure that occurred
after drainage. They realized the importance of the negative
pleural pressure and of the closed drainage and made clear
recommendations that are still valid in our days. As a result
oftherecommendationsoftheEmpyemaCommission,there
was a dramatic decrease of the mortality of parapneumonic
empyema from an average of 30% to 4.3% [7, 8].
Thoracoplasty was introduced at the end of the 19th
century as a procedure to obliterate empyema cavities by
collapsing the chest wall [9]. Many procedures have been
described and used, more or less original and more or less
popular. The most “radical” was the operation described by
Schede [10], which involved resection of the ribs, intercostal
spaces, and parietal pleura overlying the empyema; healing
of the empyema was achieved by putting in close contact the
visceral pleura with healthy tissues represented by the chest
wall muscles and subcutaneous fat [10–12].
The operation of thoracoplasty was further developed
mainly as a technique to achieve healing of TB by collapsing2 Pulmonary Medicine
the lung and had an important contribution to the develop-
ment of what is now called general thoracic surgery [13];
however, its popularity declined after the introduction of
tuberculostatic drugs in the years following immediately the
2nd World War [14]. In our days, thoracoplasty is performed
mainly as a solution for chronic empyema and most authors
use the technique described by Andrews [15, 16], with or
without diﬀerent modiﬁcations [17–19].
Muscle transposition was performed at the beginning of
the 20th century by surgeons like Abrashanoﬀ [20], Robin-
son (1915), Eggers [21], or Archibald [22], but most data
published before 1960 were case reports or small series. The
technique did not become very popular mainly due to the
lack of knowledge about how to mobilize the ﬂaps safely and
due to the absence of conditions allowing major thoracic
surgery (anesthesia, transfusion, antibiotics, etc.). It became
popular in the 1980–90s mainly due to the work of the sur-
geons (thoracic and plastic-reconstructive) from the Mayo
Clinic who showed the value of diﬀerent muscle ﬂaps in the
treatment of severe intrathoracic infections [14, 23, 24].
3. Modern Indications
From the very beginning, it must be clearly stated that tho-
racomyoplasty procedures address to a very small group
of patients with empyema. First of all, most patients with
parapneumonic eﬀusions and empyema can be cured by
antibiotics and thoracocenthesis or tube-thoracostomy, with
no need to perform major surgery [25] .I ft h i si sr e q u i r e d ,
the ﬁrst option is lung decortications, which obliterates the
spacebyreexpandingthelungandhasseveralveryimportant
advantages: no chest wall mutilation, functional recovery of
the collapsed lung, and no signiﬁcant long-term sequelae
[26]. The possibility to perform this procedure using a
minimally invasive approach makes it even more attractive
by reducing the morbidity and the postoperative pain and by
improving the esthetic aspect [27]. Decortication performed
through video-assisted thoracic surgery (VATS) is now the
ﬁrst option for most patients with empyema requiring major
surgery [28].
However,lungdecortication(openorVATS)requirestwo
major conditions in order to be successful. First, there must
be a cleavage plane allowing to decorticate the lung; if this
plane does not exist or is not clearly deﬁned, the procedure
becomes diﬃcult or even impossible due to the bleeding
and air leaks that occur during the dissection. Second,
the underlying lung parenchyma must have the ability to
reexpand and completely obliterate the pleural space. If these
two conditions are not fulﬁlled, lung decortication becomes
a hazardous and very risky procedure and thoracomyoplasty
becomes an option that should be taken into consideration
[29].
Therefore, thoracomyoplasty for empyema is nowadays
indicated in the following situations:
(i) absence of a cleavage plane allowing the surgeon to
decorticate the lung,
(ii) inability of the lung to reexpand and completely ﬁll
the pleural space,
(iii) postoperative empyema, where decortication is not
possible or has failed,
(iv) presence of bronchial ﬁstulae: their safe closure is
mandatory and suture-reinforcement using muscle
ﬂaps, with or without a thoracoplasty, is a good and
safe option,
(v) presence of unresectable lesions in the lung paren-
chyma: this diseased space must also be ﬁlled with
well-vascularized tissue.
TBempyemaisnotbyitselfanindicationforthoracomy-
oplasty, although, in the past, diﬀerent collapse techniques
were used to treat TB. However, TB patients with prolonged
medical treatments and parenchyma lesions present more
frequently with the aforementioned features, making them
candidates for thoracomyoplasty. In our experience with this
kind of surgery, almost one half of the cases had diﬀerent
forms of TB disease.
Thoracomyoplasty involves opening of the chest, resec-
tion of some parts of the chest wall, and dissection of muscle
ﬂapsonlargeareas.Therefore,itisamajorprocedureandthe
ability of the patient to tolerate it should be clearly assessed
when planning the surgery. The preoperative evaluation
should be basically the same as for any major thoracic
procedure [30] Due to the esthetic disturbance of the chest,
thoracomyoplasty procedures are less attractive for young
and female patients.
Thiskindofsurgeryinvolvesacertaindegreeofchestwall
mutilation and some functional impairment. As a matter of
fact,one of the main objective of the modern techniques is to
minimize these adverse eﬀects. However, these aspects must
beclearlydiscussedwiththepatientbeforetheoperationand
a written consent should be obtained [31, 32].
4.Basic PrinciplesandTechniques
4.1. Preoperative Preparation. It is essential in this kind of
surgery. Most patients present with an altered biological
status secondary to the infection and signiﬁcant associ-
ated diseases requiring a careful reequilibration. Antibiotics
should be administered according to the sensitivity of the
microorganisms involved. Local control of infection should
be achieved by thoracocenthesis, tube-thoracostomy, or even
open-window. Daily lavages of the empyema cavity are
required to achieve an operative ﬁeld as clean as possible.
4.2. Planning the Procedure. It must be done very carefully
and several factors should be clearly assessed:
(i) location and dimensions of the empyema cavity,
which can be well evaluated using modern CT scans
with 3D reconstructions;
(ii) presence or absence of bronchial ﬁstula, whose safe
closure is mandatory;
(iii) available ﬂaps—previous surgery may damage some
of the vascular pedicles, making some ﬂaps impos-
sible to raise—that is, myocardial revascularizationPulmonary Medicine 3
using the mammary artery or subcostal laparo-
tomy compromise the ipsilateral rectus abdominis,
standard posterolateral thoracotomy sections, the
latissimus dorsi, and so forth;
(iv) the morbidity generated by the use of a certain ﬂap
and the complexity of the mobilization.
4.3.TechnicalDetails. Inmostcasesaposterolateralthoraco-
tomy skin incision is made. After sectioning of the subcuta-
neous fat, the latissimus dorsi and the serratus anterior are
mobilized partially to allow access to the empyema cavity.
After entering the empyema cavity, the topography of the
lesion is carefully evaluated and the ﬁnal decision is made.
We prefer to start with a complete mobilization of the ﬂaps,
according to the topography of the lesions:
(i) the latissimus dorsi muscle:
(a) the standard mobilization is based on the
thoraco-dorsal vessels, resulting in a large ﬂap
that reaches almost any part of the thorax [33];
it is probably the most used ﬂap in both plastic-
reconstructive and thoracic surgery,
(b) the reversed latissimus dorsi ﬂap is based on the
secondary blood supply represented by some
perforator branches from the last intercostal
and ﬁrst lumbar vessels: it is a much more dif-
ﬁcult ﬂap with a variable anatomy and limited
arch of rotation, but it may be a good solution
for defects located in the supradiaphragmatic
area [34, 35];
(ii) t h es e r r a t u sa n t e r i o rh a sa sm a i nb l o o ds u p p l ya
branch from the thoraco-dorsal vessels (not recog-
nized by the Nomina Anatomica) which allows the
mobilization of the entire muscle. The secondary
blood supply represented by the lateral thoracic
vessels supports only a limited portion of the muscle.
When a full mobilization of the serratus anterior
is performed, it results a ﬂap with a volume that
is comparable with the latissimus dorsi and can
reach any point located in the upper half of the
thorax, including the hilar region [35, 36]. Due to the
common blood supply, the latissimus dorsi and the
serratus anterior may be raised together using the
thoraco-dorsal vessels;
(iii) the pectoralis major may be raised in more ways:
(a) using the thoracoacromial vessels, which results
in a ﬂap with good mobility that is useful for
defects located in the apex of the chest,
(b) using the perforator branches from the internal
mammary and the anterior intercostal vessels,
which results in a ﬂap with a limited mobility
suited for defects located in the upper parame-
diastinal area [37, 38];
(iv) therectusabdominisﬂapcanberaisedusingthesupe-
rior epigastric vessels, which continue the internal
mammary artery and vein; although the tip of this
ﬂap may reach the base of the neck, it is usually used
for defects located in the lower half of the chest [39];
(v) the omentum—although it is not a muscle, it is used
withthesamepurposesandprinciples;itismobilized
using the left or right gastroepiploic vessels and
brought inside the chest through a small diaphrag-
matic opening. It is an excellent material for closure
of large bronchial ﬁstulas [40];
(vi) other ﬂaps rarely used to ﬁll an infected pleural space
include the trapezius, subscapularis, infraspinatus,
external oblique, and teres major. In the available
literature, there is no important experience with
them and they should be taken into consideration
mainly when other more common neighbourhood
muscles are not available [41, 42].
Introduction of the ﬂaps inside the chest requires a sec-
ond opening, which is done by a limited rib resection (10–
15cm length, no more than one rib) to allow safe passage of
the ﬂap and its blood supply. The ﬂaps must reach the defect
without any tension or torsion. At the end of the procedure,
the muscle ﬂaps must remain with a good blood supply,
both arterial and venous. As for any procedure that involves
muscle ﬂaps, severe ischemia with necrosis will result in
complete failure of the operation [32].
Associated thoracoplasty is often necessary to achieve
complete obliteration of the infected pleural space. In
opposition to many classic procedures based on extensive
rib resection, thoracoplasty should be as limited as possible
to avoid major chest diﬀormity and long-time sequelae.
Rib resection must never expand beyond the edges of
the empyema cavity. We also believe that preservation of
the ﬁrst rib is mandatory to avoid shoulder asymmetry
and functional disturbances. When mobilized carefully, the
muscle ﬂaps may ﬁll most of the empyema cavity, as well as
the dead angles and the cul-de-sacs, thus reducing the extent
of the rib resection. The resection of the ribs should be made
using a subperiosteal plane, thus allowing some regeneration
of bone tissue, which improves the long-time rigidity of the
chest wall. Creation of intercostal ﬂaps is very easy after
thoracoplasty, by simply sectioning the remaining pleuro-
periosto-intercostal plane through the bed of the resected
ribs.
At the end of the procedure, the empyema cavity must
be completely obliterated by this combination of muscle
ﬂaps and thoracoplasty. Especially for big cavities, a certain
compromise must be found to avoid both mobilization of
multiple muscle ﬂaps and an extensive chest wall resection
(Figures 1 and 2).
Drainage of the empyema cavity is mandatory; we
usually use an irrigation-aspiration system that allows not
only drainage of the cavity, but also postoperative lavages
with diﬀerent antibiotic and disinfectant solutions. If the
mobilization of the ﬂaps is an extensive one (as it happens
in most cases), the subcutaneous space must also be drained
to avoid postoperative seroma. The wound is closed primary
with separate stitches [30, 35].4 Pulmonary Medicine
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Figure 1:Anatomicdrawingofthebloodsupplyofthemostusedextrathoracicmuscleﬂapsthataretransposedinsidethechesttoobliterate
infected spaces. From Miller et al.—Single-stage complete muscle ﬂap closure of the postpneumonectomy space: a new method and possible
solution to a disturbing complication, Ann Thorac Surg 1984; 38:227-31.
(a) (b)
(c) (d)
Figure 2: TB empyema with multiple bronchial ﬁstulae solved by thoracomyoplasty—personal collection. (a) Aspect of the cavity with
multiple large bronchial ﬁstulae (encircled area). (b) The latissimus dorsi and serratus anterior ﬂaps. (c) Closure-reinforcement of the
bronchialﬁstulae.(d)Finalaspectattheendoftheprocedure.Notetheassociatedribresectionandthecompleteobliterationoftheempyema
cavity with the use of the muscle ﬂaps.Pulmonary Medicine 5
5. PersonalExperienceand Results
from the Literature
We started to use thoracomyoplasty with extensive mobi-
lization and intrathoracic transposition of ﬂaps since 2003
and have recently published a detailed analysis of our ﬁrst
76 cases [35, 43, 44]. This is a group of desperate patients
with intrathoracic infections that were not amenable for
lung decortication and/or resection. As particular clinical
and pathological aspects of our small series, we mention the
high proportion of
(i) active TB cases (36 cases, 47%) with 28 patients still
having positive bacteriologic cultures and 7 patients
with multi-drug-resistant infections,
(ii) postoperative empyema (13 patients, 17%),
(iii) frank intrapleural rupture of a pulmonary cavity (18
patients, 24%),
(iv) bronchial ﬁstulae (26 patients, 34%).
In our series, we encountered an overall mortality of
5% (4 patients). Local complications included recurrence of
the intrathoracic infection in 4 patients (5%) that required
a modiﬁed open-window procedure, minor skin necrosis
solved by simple excision in 3 patients (4%), and external
thoracic ﬁstula solved by local lavages in 2 patients (3%).
Postoperative hospitalization ranged between 4 and 180 days
with an average of 40±5 days (conﬁdence level: 95%). At 3-
month followup, 66 patients (91%) of the survivors returned
to an almost normal life compared with their preoperative
status.
Other authors have recently published their experience
with this kind of surgery (with or without diﬀerent technical
details) with quite similar results, showing that in selected
cases thoracomyoplasty may be a valuable solution [19, 45–
49]. There seems to be a an overall mortality around 5%
with a success rate (deﬁned as chest closure and cure of the
empyema with no recurrence of the intrathoracic infection)
of over 90%.
There are many unsolved problems since due to the
rarity of these procedures and the great heterogenicity of the
patientswecannottalkaboutrandomizedstudiesorevenfair
retrospective comparisons. As a direct result, some questions
are still to be answered: which is the best ﬂap and when and
how a certain ﬂap should be mobilized, what is the number
of ﬂaps that should be mobilized, what should be the extent
of rib resection, and so forth.
6. Conclusions
Thoracomyoplasty remains a valuable surgical solution for
diﬃcult empyema cases not amenable to lung decortication.
Its value comes from the fact that it may be one of the
last solutions for some desperate cases. It achieves healing
by immediate complete obliteration of the empyema cavity.
Compared to classic thoracoplasty procedures—including
the operation described by Andrews—the use of muscle
ﬂaps mobilized using techniques borrowed from plastic-
reconstructive surgery helps improving the results mainly by
limiting the extension of the rib resection and by ﬁlling the
empyema cavity with a well-vascularised tissue, which is able
to ﬁght against infection and promote healing. Although not
commonly indicated in our days, thoracic surgeons should
be familiar with this kind of procedures [50].
References
[1] S. F. Lee, D. Lawrence, H. Booth, S. Morris-Jones, B. MacRae,
and A. Zumla, “Thoracic empyema: current opinions in med-
ical and surgical management,” Current Opinion in Pulmonary
Medicine, vol. 16, no. 3, pp. 194–200, 2010.
[2] L. Kern, J. Robert, and M. Brutsche, “Management of para-
pneumonic eﬀusion and empyema: medical thoracoscopy and
surgical approach,” Respiration, vol. 82, no. 2, pp. 193–195,
2011.
[3] J. Nielsen, C. N. Meyer, and S. Rosenlund, “Outcome and
clinical characteristics in pleural empyema: a retrospective
study,” Scandinavian Journal of Infectious Diseases, vol. 43, no.
6-7, pp. 430–435, 2011.
[4] T.F.Molnar,“Currentsurgicaltreatmentofthoracicempyema
inadults,”EuropeanJournalofCardio-thoracicSurgery,vol.32,
no. 3, pp. 422–430, 2007.
[5] R. K. Dewan, “Surgery for pulmonary tuberculosis—a 15-year
experience,” European Journal of Cardio-thoracic Surgery, vol.
37, no. 2, pp. 473–477, 2010.
[6] H. Christopoulou-Aletra and N. Papavramidou, “”Empye-
mas” of the thoracic cavity in the hippocratic corpus,” Annals
of Thoracic Surgery, vol. 85, no. 3, pp. 1132–1134, 2008.
[7] E. A. Graham and R. D. Bell, “Open pneumothorax: its
relation to the treatment of empyema,” The American Journal
of the Medical Sciences, vol. 156, pp. 839–871, 1918.
[8] F. C. Aboud and A. C. Verghese, “Evarts ambrose graham,
empyema, and the dawn of clinical understanding of negative
intrapleural pressure,” Clinical Infectious Diseases, vol. 34, no.
2, pp. 198–203, 2002.
[ 9 ] J .A .E s t l a n d e r ,“ R ´ esection des cˆ otes dans l’empy` eme
chronique,” Revista Medico, vol. 3, pp. 157–170, 1879.
[10] M. Schede, “Die behandlung der empyeme,” Verh Long Innere
Med Wiesbaden, vol. 9, pp. 41–141, 1890.
[11] P. V.-H. Botianu, “Re-evaluation of the Schede thoracoplasty,”
Journal of Thoracic Surgery, vol. 7, no. 1, pp. 71–78, 2005.
[12] P.V.-H.Botianu,A.Butiurca,A.Dobricaetal.,“Schedeproce-
dureandmuscularplombageforamultirelapsedTBempyema
with pleuro-cutaneous ﬁstula,” Acta Medica Marisiensis, vol.
54, no. S3, pp. 69–72, 2008.
[13] J. Alexander, “Some advances in the technic of thoracoplasty,”
Annals of Surgery, vol. 104, no. 4, pp. 545–551, 1936.
[14] J. Miller, “The history of surgery of empyema, thoracoplasty,
Eloesser ﬂap, and muscle ﬂap transposition,” Chest Surgery
Clinics of North America, vol. 10, no. 1, pp. 45–53, 2000.
[15] N. C. Andrews, “Thoracomediastinal plication: a surgical
technique for chronic empyema,” The Journal of Thoracic and
Cardiovascular Surgery, vol. 41, pp. 809–816, 1961.
[16] N. C. Andrews, “The surgical treatment of chronic empyema,”
Diseases of the Chest, vol. 47, pp. 533–538, 1965.
[ 1 7 ] E .C o r n e t ,H .D u p o n ,P .C o i ﬀard, and A. Rembeaux,
“Thoracopleuroplasties for empyema according to Andrews’
method(18cases),”AnnalesdeChirurgieThoraciqueetCardio-
Vasculaire, vol. 4, no. 4, pp. 509–515, 1965.6 Pulmonary Medicine
[18] A. M. Botianu, “Personal procedure of thoracopleuroplasty
for the treatment of the thoracic empyema, with or without
bronchial ﬁstula,” Journal of Thoracic Surgery,v o l .1 ,n o .3 ,p p .
251–260, 1996.
[19] P. Icard, J. P. Le Rochais, B. Rabut, S. Cazaban, B. Martel,
and C. Evrard, “Andrews thoracoplasty as a treatment of post-
pneumonectomy empyema: experience in 23 cases,” Annals of
Thoracic Surgery, vol. 68, no. 4, pp. 1159–1164, 1999.
[20] G. Abrashanoﬀ, “Plastische Methode der Schliessung von Fis-
telgangen, welche von inneren Organen kommen,” Zentralbl
Chir, vol. 38, pp. 186–187, 1911.
[21] C. Eggers, “The treatment of bronchial ﬁstulae,” Annals of Sur-
gery, vol. 72, pp. 345–351, 1920.
[22] E. Archibald, “On extra-pleural thoracoplasty,” Canadian
Medical Association Journal, vol. 16, no. 4, pp. 433–435, 1926.
[23] P. G. Arnold and P. C. Pairolero, “Intrathoracic muscle ﬂaps:
a 10-year experience in the management of life-threatening
infections,” Plastic and Reconstructive Surgery,v o l .8 4 ,n o .1 ,
pp. 92–98, 1989.
[24] P.C.PairoleroandP.G.Arnold,“Intrathoracictransferofﬂaps
for ﬁstulas, exposed prosthetic devices, and reinforcement of
suture lines,” Surgical Clinics of North America, vol. 69, no. 5,
pp. 1047–1059, 1989.
[25] H. E. Davies, A. Rosenstengel, and Y. C.G. Lee, “The dimin-
ishing role of surgery in pleural disease,” Current Opinion in
Pulmonary Medicine, vol. 17, no. 4, pp. 247–254, 2011.
[26] M. Gokce, E. Okur, V. Baysungur, G. Ergene, G. Sevilgen, and
S. Halezeroglu, “Lung decortication for chronic empyaema:
eﬀects on pulmonary function and thoracic asymmetry in the
late period,” European Journal of Cardio-Thoracic Surgery, vol.
36, no. 4, pp. 754–758, 2009.
[27] B. C. Tong, J. Hanna, E. M. Toloza et al., “Outcomes of
video-assisted thoracoscopic decortication,” Annals of Tho-
racic Surgery, vol. 89, no. 1, pp. 220–225, 2010.
[28] A. Chambers, T. Routledge, J. Dunning, and M. Scarci, “Is
video-assisted thoracoscopic surgical decortication superior
to open surgery in the management of adults with primary
empyema?” Interactive Cardiovascular and Thoracic Surgery,
vol. 11, no. 2, pp. 171–177, 2010.
[29] Y.Shiraishi,“Surgicaltreatmentofchronicempyema,”General
Thoracic and Cardiovascular Surgery, vol. 58, no. 7, pp. 311–
316, 2010.
[30] P. V.-H. Botianu and A. M. Botianu, “Role of thoracomy-
oplasty procedures in modern surgery for intrathoracic sup-
purations,”inTopicsinThoracicSurgery,P .F .G.Cardosso ,Ed.,
pp. 309–326, InTech, Rijeka, Croatia, 2012.
[31] S. J. Mathes and S. Nahai, Clinical Atlas of Muscle and
Musculocutaneous Flaps, CV Mosby, St. Louis, Mo, USA, 1979.
[ 3 2 ]J .B .M c C r a wa n dP .G .A r n o l d ,McCraw and Arnold’s Atlas of
Muscle and Musculocutaneous Flaps, Hampton Press, Norfolk,
Va, USA, 1987.
[33] A. Abolhoda, G. A. Wirth, T. D. Bui, and J. C. Milliken,
“Harvest technique for pedicled transposition of latissimus
dorsi muscle: an old trade revisited,” European Journal of
Cardio-Thoracic Surgery, vol. 33, no. 5, pp. 928–930, 2008.
[34] H. Nomori, T. Hasegawa, and R. Kobayashi, “The “reversed”
latissimus dorsi muscle ﬂap with conditioning delay for
closure of a lower thoracic tuberculous empyema,” Thoracic
and Cardiovascular Surgeon, vol. 42, no. 3, pp. 182–184, 1994.
[35] P.V.H.Botianu,A.M.Botianu,V.Bacarea,andA.C.Dobrica,
“Thoracodorsal versus reversed mobilisation of the latissimus
dorsi muscle for intrathoracic transposition,” European Jour-
nal of Cardio-thoracic Surgery, vol. 38, no. 4, pp. 461–465,
2010.
[36] P. G. Arnold, P. C. Pairolero, and J. C. Waldorf, “The serratus
anterior muscle: intrathoracic and extrathoracic utilization,”
Plastic and Reconstructive Surgery, vol. 73, no. 2, pp. 240–246,
1984.
[ 3 7 ] H .N o m o r i ,H .H o r i o ,T .H a s e g a w a ,a n dK .S u e m a s u ,
“Intrathoracic transposition of a pectoralis major and pec-
toralis minor muscle ﬂap for empyema in patients previously
subjected to posterolateral thoracotomy,” Surgery Today, vol.
31, no. 4, pp. 295–299, 2001.
[38] C. D. Shipkov and A. P. Uchikov, “Pectoralis major and pec-
toralisminormuscleﬂapforpostpneumonectomyempyema,”
Surgery Today, vol. 40, no. 3, p. 285, 2010.
[ 3 9 ]H .N o m o r i ,H .H o r i o ,R .K o b a y a s h i ,a n dT .H a s e g a w a ,
“Intrathoracic transposition of the musculocutaneous ﬂap in
treating empyema,” Thoracic and Cardiovascular Surgeon, vol.
43, no. 3, pp. 171–175, 1995.
[40] M. Kitano, “Omentoplasty in thoracic surgery,” General
Thoracic and Cardiovascular Surgery, vol. 56, no. 10, pp. 483–
489, 2008.
[41] P. Fuchs, W. Schreiner, T. P. Wolter, R. Autschbach, H. Sirbu,
and N. Pallua, “A four-muscle-ﬂap for thoracomyoplasty
in patients with sacriﬁced thoracodorsal vessels,” Journal of
Plastic, Reconstructive and Aesthetic Surgery,v o l .6 4 ,n o .3 ,p p .
335–338, 2011.
[42] W. Schreiner, P. Fuchs, R. Autschbach, N. Pallua, and H. Sirbu,
“Modiﬁedtechniqueforthoracomyoplastyafterposterolateral
thoracotomy,” Thoracic and Cardiovascular Surgeon, vol. 58,
no. 2, pp. 98–101, 2010.
[43] P.V.H.Botianu,A.M.Botianu,A.C.Dobrica,andV.Bacarea,
“Intrathoracic transposition of the serratus anterior muscle
ﬂap—personalexperiencewith65consecutivepatients,”Euro-
pean Journal of Cardio-thoracic Surgery, vol. 38, no. 6, pp. 669–
673, 2010.
[44] P. V. H. Botianu, A. C. Dobrica, A. Butiurca, and A. M.
Botianu, “Complex space-ﬁlling procedures for intrathoracic
infections—personal experience with 76 consecutive cases,”
European Journal of Cardio-thoracic Surgery,v o l .3 7 ,n o .2 ,p p .
478–481, 2010.
[45] M. Garc´ ıa-Yuste, G. Ramos, J. L. Duque et al., “Open-window
thoracostomy and thoracomyoplasty to manage chronic pleu-
ral empyema,” Annals of Thoracic Surgery,v o l .6 5 ,n o .3 ,p p .
818–822, 1998.
[46] E. Jadczuk, “Postpneumonectomy empyema,” European Jour-
nal of Cardio-thoracic Surgery, vol. 14, no. 2, pp. 123–126,
1998.
[47] J. F. Regnard, M. Alifano, P. Puyo, E. Fares, P. Magdeleinat,
and P. Levasseur, “Open window thoracostomy followed by
intrathoracic ﬂap transposition in the treatment of empyema
complicating pulmonary resection,” Journal of Thoracic and
Cardiovascular Surgery, vol. 120, no. 2, pp. 270–275, 2000.
[48] A. Krassas, R. Grima, P. Bagan et al., “Current indications and
results for thoracoplasty and intrathoracic muscle transposi-
tion,” European Journal of Cardio-thoracic Surgery, vol. 37, no.
5, pp. 1215–1220, 2010.
[49] A. Stefani, R. Jouni, M. Alifano et al., “Thoracoplasty in the
current practice of thoracic surgery: a single-institution 10-
year experience,” Annals of Thoracic Surgery,v o l .9 1 ,n o .1 ,p p .
263–268, 2011.
[50] M. Riquet, “Thoracomyoplasty (Editorial comment),” Euro-
pean Journal of Cardio-thoracic Surgery, vol. 37, no. 2, p. 482,
2010.